Korro Bio appoints Rachel Meyers, Ph.D. to Board of Directors

Korro Bio, Inc.

Rachel Meyers, Ph.D. appointed as Class I director effective November 27, 2023.
Meyers also appointed to Nominating and Corporate Governance Committee.
She will receive non-employee director compensation per company policy.
Standard indemnification agreement entered with Meyers.
No material interest in any transaction required to be disclosed.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Rachel Meyers, Ph.D.

Class I Director

KRRO · Korro Bio, Inc.

Effective: 2023-11-27
Filed: November 29, 2023, 6:59 PM ET

On November 27, 2023, upon the recommendation of its Nominating and Corporate Governance Committee, or the NCG Committee, our Board of Directors, or the Board, appointed Rachel Meyers, Ph.D. as a Class I director, effective November 27, 2023

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Rachel Meyers, Ph.D. was appointed as Class I Director at Korro Bio, Inc..

Action: appointed
Role: Class I Director

Exact text from the filing

On November 27, 2023, upon the recommendation of its Nominating and Corporate Governance Committee, or the NCG Committee, our Board of Directors, or the Board, appointed Rachel Meyers, Ph.D. as a Class I director, effective November 27, 2023

View on SEC.gov

Korro Bio, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-285164

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.